Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PI3Kβ is a class IA phosphoinositide 3-kinase catalytic subunit that plays critical roles in cell growth, proliferation, differentiation, motility, survival, and intracellular trafficking. It integrates signals from receptor tyrosine kinases (RTKs), G protein–coupled receptors (GPCRs), and Rho-family small GTPases. PI3Kβ regulates invadopodia maturation in tumor cells and is essential for osteoclast development/function. Dysregulation or mutation contributes to cancer progression/metastasis and bone disorders. It is ubiquitously expressed but has particularly important functions in reproductive organs, immune cells, bone-resorbing osteoclasts and platelets.
PI3Kβ inhibitors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoinositide 3-kinase beta isoform (PI3Kβ).